Terms: = Breast cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4
1208 results:
1. Elongin B promotes breast cancer progression by ubiquitinating tumor suppressor p14/arf.
Sui XY; Ma XY; Hou Y; Cao SW; Wang ZQ; Jia LJ; Fan L; Shao ZM; Zhang WJ
Cell Biol Toxicol; 2024 Apr; 40(1):24. PubMed ID: 38653919
[TBL] [Abstract] [Full Text] [Related]
2. The association between sodium glucose cotransporter-2 inhibitors vs dipeptidyl peptidase-4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population-based cohort study.
Ziser KED; Wood S; Tan GSQ; Morton JI; Shaw JE; Bell JS; Ilomaki J
J Diabetes; 2024 Apr; 16(4):e13507. PubMed ID: 38599885
[TBL] [Abstract] [Full Text] [Related]
3. Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions.
Gerosa R; De Sanctis R; Jacobs F; Benvenuti C; Gaudio M; Saltalamacchia G; Torrisi R; Masci G; Miggiano C; Agustoni F; Pedrazzoli P; Santoro A; Zambelli A
Crit Rev Oncol Hematol; 2024 Apr; 196():104324. PubMed ID: 38462150
[TBL] [Abstract] [Full Text] [Related]
4. [A Case Report of Metastatic breast cancer with Peritoneal Metastasis and Massive Ascites Responding to CDK4/6 Inhibitor(Palbociclib)].
Yao S; Goi T; Takahashi M; Kono H; Yokoi S; Maeda H
Gan To Kagaku Ryoho; 2024 Feb; 51(2):214-216. PubMed ID: 38449417
[TBL] [Abstract] [Full Text] [Related]
5. Three-Dimensional Shear Wave Elastography Using Acoustic Radiation Force and a 2-D Row-Column Addressing (RCA) Array.
Dong Z; Lok UW; Lowerison MR; Huang C; Chen S; Song P
IEEE Trans Ultrason Ferroelectr Freq Control; 2024 Apr; 71(4):448-458. PubMed ID: 38363671
[TBL] [Abstract] [Full Text] [Related]
6. Unique E2-binding specificity of artificial RING fingers in cancer cells.
Miyamoto K; Tadokoro T; Matsumoto A
Sci Rep; 2024 Jan; 14(1):2545. PubMed ID: 38291082
[TBL] [Abstract] [Full Text] [Related]
7. Risk of malignancy in incidental oropharyngeal lesions exhibiting fluorodeoxyglucose uptake which proceed to tissue biopsy.
Key S; Chia C; Magarey M; Dixon B
ANZ J Surg; 2024 Feb; 94(1-2):122-127. PubMed ID: 38115646
[TBL] [Abstract] [Full Text] [Related]
8. Novel 2 Gene Signatures Associated With breast cancer Proliferation: Insights From Predictive Differential Gene Expression Analysis.
Ibrahim A; Toss MS; Alsaleem M; Makhlouf S; Atallah N; Green AR; Rakha EA
Mod Pathol; 2024 Feb; 37(2):100403. PubMed ID: 38104894
[TBL] [Abstract] [Full Text] [Related]
9. First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative breast cancer: Clinical and Biomarker Results.
Schmid P; Turner NC; Barrios CH; Isakoff SJ; Kim SB; Sablin MP; Saji S; Savas P; Vidal GA; Oliveira M; O'Shaughnessy J; Italiano A; Espinosa E; Boni V; White S; Rojas B; Freitas-Junior R; Chae Y; Bondarenko I; Lee J; Torres Mattos C; Martinez Rodriguez JL; Lam LH; Jones S; Reilly SJ; Huang X; Shah K; Dent R
Clin Cancer Res; 2024 Feb; 30(4):767-778. PubMed ID: 38060199
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China.
Ren M; Cai X; Jia L; Bai Q; Zhu X; Hu X; Wang Q; Luo Z; Zhou X
BMC Cancer; 2023 Dec; 23(1):1175. PubMed ID: 38041048
[TBL] [Abstract] [Full Text] [Related]
11. Immunoexpression of HER2 pathway related markers in HER2 invasive breast carcinomas treated with trastuzumab.
Franco AFDV; Malinverni ACM; Waitzberg AFL
Pathol Res Pract; 2023 Dec; 252():154917. PubMed ID: 37977031
[TBL] [Abstract] [Full Text] [Related]
12. CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
Pita JM; Raspé E; Coulonval K; Decaussin-Petrucci M; Tarabichi M; Dom G; Libert F; Craciun L; Andry G; Wicquart L; Leteurtre E; Trésallet C; Marlow LA; Copland JA; Durante C; Maenhaut C; Cavaco BM; Dumont JE; Costante G; Roger PP
Front Endocrinol (Lausanne); 2023; 14():1247542. PubMed ID: 37964967
[TBL] [Abstract] [Full Text] [Related]
13. mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers.
Bouamar H; Broome LE; Lathrop KI; Jatoi I; Brenner AJ; Nazarullah A; Gorena KM; Garcia M; Chen Y; Kaklamani V; Sun LZ
Breast Cancer Res; 2023 Oct; 25(1):131. PubMed ID: 37904250
[TBL] [Abstract] [Full Text] [Related]
14. Low-Density Lipoprotein Contributes to Endometrial Carcinoma Cell Proliferation, Migration, and Invasion by Activating the JAK-STAT Signaling Pathway.
Shen L; Zhang C; Cui K; Liang X; Zhu G
Anal Cell Pathol (Amst); 2023; 2023():4015167. PubMed ID: 37900720
[TBL] [Abstract] [Full Text] [Related]
15. Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study.
Mehanna H; Rapozo D; von Zeidler SV; Harrington KJ; Winter SC; Hartley A; Nankivell P; Schache AG; Sloan P; Odell EW; Thavaraj S; Hunter KD; Shah KA; Thomas GJ; Long A; Amel-Kashipaz R; Brown RM; Conn B; Hall GL; Matthews P; Weir J; Yeo Y; Pring M; West CML; McCaul J; Golusinski P; Sitch A; Spruce R; Batis N; Bryant JL; Brooks JM; Jones TM; Buffa F; Haider S; Robinson M
Clin Cancer Res; 2024 Jan; 30(2):356-367. PubMed ID: 37870417
[TBL] [Abstract] [Full Text] [Related]
16. cdkn2a was a cuproptosis-related gene in regulating chemotherapy resistance by the MAGE-A family in breast cancer: based on artificial intelligence (AI)-constructed pan-cancer risk model.
Wan H; Yang X; Sang G; Ruan Z; Ling Z; Zhang M; Liu C; Hu X; Guo T; He J; Liu D; Pei J
Aging (Albany NY); 2023 Oct; 15(20):11244-11267. PubMed ID: 37857018
[TBL] [Abstract] [Full Text] [Related]
17. Sclareol induces cell cycle arrest and ROS-mediated apoptosis and ferroptosis in lung adenocarcinoma cells.
Rah B; Shafarin J; Hamad M; Muhammad JS
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23563. PubMed ID: 37850667
[TBL] [Abstract] [Full Text] [Related]
18. ABERRANT METHYLATION OF cancer-RELATED GENES IN VIETNAMESE breast cancer PATIENTS: ASSOCIATIONS WITH CLINICOPATHOLOGICAL FEATURES.
Dieu Vuong L; Ngoc Nguyen Q
Exp Oncol; 2023 Oct; 45(2):195-202. PubMed ID: 37824772
[TBL] [Abstract] [Full Text] [Related]
19. The Identification of Gamma-Glutamyl Hydrolase in Uterine Corpus Endometrial Carcinoma: a Predictive Model and Machine Learning.
Zhu C; Du Y; Huai Q; Fang N; Xu W; Yang J; Li X; Zhang Y; Zhang X; Dai H; Li X; Wang H; Dai Y
Reprod Sci; 2024 Feb; 31(2):532-549. PubMed ID: 37798609
[TBL] [Abstract] [Full Text] [Related]
20. Diagnosis and Prognosis of Thyroid cancer by Immune-related Genes.
Li J; Li Z; Zhao P
Am J Clin Oncol; 2024 Jan; 47(1):1-10. PubMed ID: 37779238
[TBL] [Abstract] [Full Text] [Related]
[Next]
